SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-003181
Filing Date
2019-03-12
Accepted
2019-03-12 16:01:38
Documents
67
Period of Report
2019-01-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 458190
2 ex31-1.htm EX-31.1 19729
3 ex31-2.htm EX-31.2 19668
4 ex32-1.htm EX-32.1 7069
5 ex32-2.htm EX-32.2 7429
6 GRAPHIC image_003.jpg GRAPHIC 76360
  Complete submission text file 0001493152-19-003181.txt   2911834

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE adxs-20190131.xml EX-101.INS 428816
8 XBRL SCHEMA FILE adxs-20190131.xsd EX-101.SCH 36866
9 XBRL CALCULATION FILE adxs-20190131_cal.xml EX-101.CAL 59433
10 XBRL DEFINITION FILE adxs-20190131_def.xml EX-101.DEF 100710
11 XBRL LABEL FILE adxs-20190131_lab.xml EX-101.LAB 255163
12 XBRL PRESENTATION FILE adxs-20190131_pre.xml EX-101.PRE 204395
Mailing Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-36138 | Film No.: 19675080
SIC: 2834 Pharmaceutical Preparations